Reply to: Extended adjuvant temozolomide in newly diagnosed glioblastoma: the more, the better?

Neuro Oncol. 2021 Sep 1;23(9):1616-1618. doi: 10.1093/neuonc/noab125.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Glioblastoma* / drug therapy
  • Humans
  • Temozolomide

Substances

  • Temozolomide